A carregar...
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain. These medications impact eating behavior, presumably via their impact on food reward. However, only bupropion induces weight loss in obese individuals,...
Na minha lista:
| Publicado no: | Patient Prefer Adherence |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862388/ https://ncbi.nlm.nih.gov/pubmed/27217728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S84778 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|